Literature DB >> 9291994

Inhibition of human leukocyte elastase activity by chondroitin sulfates.

N Volpi1.   

Abstract

Chondroitin sulfates with different properties and devoid of appreciable anticoagulant activity were evaluated for their capacity to inhibit human leukocyte elastase activity in vitro by using a chromogenic substrate. Fractions with various mass and the same charge density were tested. The chondroitin sulfates with a molecular mass greater than about 2000 inhibited human leukocyte elastase activity to the same extent, whilst the fractions with a molecular mass of 1960 and 1020 were much less effective. The percentage inhibition of human leukocyte elastase activity increased based on the charge density of chondroitin sulfates. In particular, the inhibition of the enzymatic activity decreased with the percentage of non-sulfated disaccharide and increased with the amount of disaccharide-2,6-disulfated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9291994     DOI: 10.1016/s0009-2797(97)00045-8

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  8 in total

1.  Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly.

Authors:  A Hinek; S E Wilson
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  Decreased elastin deposition and high proliferation of fibroblasts from Costello syndrome are related to functional deficiency in the 67-kD elastin-binding protein.

Authors:  A Hinek; A C Smith; E M Cutiongco; J W Callahan; K W Gripp; R Weksberg
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

Review 3.  Sulfated Non-Saccharide Glycosaminoglycan Mimetics as Novel Drug Discovery Platform for Various Pathologies.

Authors:  Daniel K Afosah; Rami A Al-Horani
Journal:  Curr Med Chem       Date:  2020       Impact factor: 4.530

4.  Novel low molecular weight lignins as potential anti-emphysema agents: In vitro triple inhibitory activity against elastase, oxidation and inflammation.

Authors:  Bhawana Saluja; Jay N Thakkar; Hua Li; Umesh R Desai; Masahiro Sakagami
Journal:  Pulm Pharmacol Ther       Date:  2012-12-29       Impact factor: 3.410

5.  A versatile pH sensitive chondroitin sulfate-PEG tissue adhesive and hydrogel.

Authors:  Iossif Strehin; Zayna Nahas; Karun Arora; Thao Nguyen; Jennifer Elisseeff
Journal:  Biomaterials       Date:  2010-01-04       Impact factor: 12.479

Review 6.  Marine polysaccharides: a source of bioactive molecules for cell therapy and tissue engineering.

Authors:  Karim Senni; Jessica Pereira; Farida Gueniche; Christine Delbarre-Ladrat; Corinne Sinquin; Jacqueline Ratiskol; Gaston Godeau; Anne-Marie Fischer; Dominique Helley; Sylvia Colliec-Jouault
Journal:  Mar Drugs       Date:  2011-09-23       Impact factor: 6.085

7.  Fucosylated chondroitin sulfates from the body wall of the sea cucumber Holothuria forskali: conformation, selectin binding, and biological activity.

Authors:  Charalampos G Panagos; Derek S Thomson; Claire Moss; Adam D Hughes; Maeve S Kelly; Yan Liu; Wengang Chai; Radhakrishnan Venkatasamy; Domenico Spina; Clive P Page; John Hogwood; Robert J Woods; Barbara Mulloy; Charlie D Bavington; Dušan Uhrín
Journal:  J Biol Chem       Date:  2014-08-21       Impact factor: 5.157

8.  Unusual glycosaminoglycans from a deep sea hydrothermal bacterium improve fibrillar collagen structuring and fibroblast activities in engineered connective tissues.

Authors:  Karim Senni; Farida Gueniche; Sylvie Changotade; Dominique Septier; Corinne Sinquin; Jacqueline Ratiskol; Didier Lutomski; Gaston Godeau; Jean Guezennec; Sylvia Colliec-Jouault
Journal:  Mar Drugs       Date:  2013-04-23       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.